MCRB
Seres Therapeutics Inc
2.90$
+1.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19,114.5% | -74,217.2% | – | – | – | -652.6% | – | – | 628.5% | -3,358.4% | -4,569.8% | -3,042.7% | -2,722.1% | |
| 543.2% | 2,550.0% | – | – | – | 18.2% | – | – | 297.4% | 217.8% | 218.2% | 91.0% | 183.2% | |
| 2,797.7% | 7,946.9% | – | – | – | 63.2% | – | – | 707.1% | 730.4% | 493.3% | 236.3% | 487.8% | |
| -7,350.6% | -24,045.3% | – | – | – | -505.6% | – | – | -3,318.8% | -1,260.7% | -348.9% | -5,064.9% | -2,957.9% | |
| 579.7% | 1,370.3% | – | – | – | 1.5% | – | – | 2.3% | 6.6% | 0.0% | 0.0% | 2.0% | |
| -579.7% | -1,370.3% | – | – | – | -1.5% | – | – | -2.3% | 41.3% | – | 1.9% | – | |
| – | – | – | – | – | 0.0% | – | – | – | 0.0% | – | – | – | |
| 465.5% | 10,045.3% | – | – | – | 29.2% | – | – | 17.4% | 2,889.7% | 119.6% | 233.0% | 789.2% | |
| -19,228.4% | -65,542.2% | – | – | – | -625.0% | – | – | 643.6% | -427.4% | -4,450.3% | -2,807.7% | -1,923.0% | |
| -19,694.2% | -75,587.5% | – | – | – | -654.1% | – | – | 626.2% | -3,365.1% | -4,569.8% | -3,042.7% | -2,724.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.